Drug Discovery India 2013

Pharmaceutical industry is utilizing a plethora of novel approaches, techniques and technologies for Drug Design and Discovery. Use of novel interdisciplinary approaches, developed by understanding integrated biological systems and processes at the functional and molecular levels, has made the discovery process more rational, but complex too. Therefore for optimizing the discovery and development of new molecular entities it is a current practice to follow collaborative research amongst interdisciplinary academic/research centers, government agencies and pharmaceutical industry. 

Dr. Rathnam Chatgutru, (Senior Director, SRI International, USA) serving as Chairperson, Drug Discovery India 2013, will provide an excellent platform for researchers from all facets of drug discovery research an unprecedented opportunity  to explore the contract research and collaborative options amongst various research fraternities. Planned open panel discussions and break-out sessions on key thematic areas are sure to energize the participants in defining the drug discovery landscape, especially in the Indian context, and offer ways and means to de-risk the patent cliff experienced by the pharmaceutical industry in recent years.

The conference will be co-located with Genomic & Proteomics Research and Microfluidics & Lab-on-a-Chip meetings will be held at Sheraton Hotel at Brigade Gateway, Bangalore, India. Registered delegates will have unrestricted access to all co-located meetings ensuring a comprehensive learning and sharing experience as well as being financially beneficial for attendees. 

Running alongside the Drug Discovery India 2013 conference will be an Exhibition covering the latest technological advances and associated services within these fields. We look forward to welcoming you at the Drug Discovery India 2013 Conference and Exhibition and hope that the two days will be both informative and enjoyable.

Conference Chair

Dr. Rathnam Chuguturu
Senior Director, SRI International, USA

International Advisory Board Members and/or Session Chairs
Dr. V.N. Balaji, CSO, Jubilant Biosys, Bengaluru, India
Dr. Krishna K Banaudha, Professor, George Washington University, Washington DC, USA
Dr. Hakim Djballah, Director, Memorial Sloan Kettering Cancer Center, New York, USA
Dr. Walderez Dutra, Professor, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
Dr. Sudarsanam Gudiwada, Professor, SV University, Tirupati, India
Dr. Krishna Kodukula, Executive Director, SRI International, Harrisonburg, VA, USA
Dr. A.K. Madan, Professor, University of Health Sciences, Rohtak, India
Dr. Ulf Nehrbass, Director, Institut Pasteur-Korea, Gyeonggi-do, Korea
Dr. Bhushan Patwardhan, Professor, University of Pune, Pune, India
Dr. Steve Scypinski, Vice President, Bristol-Meyers Squibb Centre, Lawrenceville, USA
Dr. Spencer Shorte, Group Leader, Institut Pasteur, Paris, France
Dr. Litao Zhang, Executive Director, Bristol-Meyers Squibb Centre, Princeton, USA

Keynote Speakers

Tushar Chakraborty Director, Central Drug Research Institute	Hakim Djaballah Director, Memorial Sloan Kettering Cancer Center	Kattesh Katti Director, University of Missouri	Anil Madan Professor, Pandit B D Sharma University of Health Sciences	Ulf Nehrbass Director/CEO, Institut Pasteur Korea	Bhushan Patwardhan Professor, Institute of Ayurveda and Integrative Medicine

Corporate Sponsors	Media Sponsors	Primary Media Partner Official Journal Partner Web Sponsor	Networking